Related Experiment Video
Updated: Aug 5, 2026
Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
The Unregulated Probiotic Market
1University of L'Aquila, L'Aquila, Italy.
Background & Aims:
This narrative review provides an overview of the current regulation of probiotics, with a focus on those used for the dietary management of medical conditions (Medical Foods).
Findings:
The probiotic market has grown rapidly, both for foods and supplements intended to enhance wellness in healthy individuals, and for preparations for the dietary management of disease. Regulation of probiotics varies between regions. Unless they make specific disease-related health claims, probiotics are regulated as food supplements and regulation is focused on the legitimacy of any claims, rather than efficacy, safety and quality. Many properties of probiotics are strain-specific, and safety and efficacy findings associated to specific formulations should not be generalized to other probiotic products. Manufacturing processes, conditions and ingredients are important determinants of product characteristics and changes to manufacturing are likely to give rise to a product not identical to the "original" in efficacy and safety if proper measures and controls are not taken. Current trademark law and the lack of stringent regulation of probiotic manufacturing mean that the trademark owner can commercialize any formulation under the same brand, even if significantly different from the original. These regulatory deficits may have serious consequences for patients where probiotics are used as part of clinical guideline-recommended management of serious conditions such as inflammatory bowel diseases, and may make doctors liable for prescribing a formulation not previously tested for safety and efficacy.
Conclusions:
Current regulation of probiotics is inadequate to protect consumers and doctors, especially when probiotics are aimed at the dietary management of serious conditions.
Insights
Current regulations for probiotics, especially medical foods, are insufficient. This lack of oversight risks patient safety and physician liability due to inconsistent product quality and unverified efficacy.
Area of Science:
- Microbiology
- Nutritional Science
- Regulatory Science
Background:
- The global market for probiotics, encompassing wellness supplements and medical foods, has experienced significant expansion.
- Probiotic regulation is inconsistent across different regions, often treating them as food supplements unless specific disease claims are made.
Purpose of the Study:
- To review the current regulatory landscape for probiotics.
- To focus on probiotics utilized in the dietary management of medical conditions, often termed Medical Foods.
Main Methods:
- This study is a narrative review.
- It synthesizes information on the regulatory status and challenges associated with probiotic products.
Main Results:
- Probiotic regulation primarily focuses on claim legitimacy rather than rigorous efficacy, safety, and quality assessments.
- Strain-specific properties mean findings for one probiotic cannot be generalized to others.
- Manufacturing variations and weak trademark regulations allow for significant product differentiation under the same brand, potentially compromising safety and efficacy.
Conclusions:
- Existing probiotic regulations are inadequate for safeguarding consumers and healthcare providers.
- These regulatory gaps pose risks, particularly when probiotics are used for serious medical conditions like inflammatory bowel diseases, potentially leading to patient harm and physician liability.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
01:28Biological Methods for Microbial Control
01:29Microbes in Food Production
01:27Microbes in the Production of Fermented Foods
01:22Probiotics
01:21Microbiota Modulation by Antibiotics